TFF3 and colorectal carcinoma: We have also provided evidence that pharmacological inhibition of TFF3 with a novel specific small molecule TFF3 inhibitor in CMS4 CRC suppresses TFF3-induced oncogenic behaviour and potentiates the efficacy of 5-FU.